Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around ...

Adobe announced the general availability of Adobe Real-Time CDP Collaboration in the U.S., a new offering that enables advertisers and publishers to tackle a changing advertising landscape. Brands ...

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...

FRANKFURT, March 6 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on ... Macro Matterscategory Canada's January trade surplus at 32-month high as firms stockpile on tariff threat 11:04 PM UTC ...

HYDERABAD, India, Feb 26 (Reuters) - Drugmaker Merck (MRK.N), opens new tab, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the ...

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

Merck (MRK) has been adjusting Keytruda to make it easier to use and to protect the company for after the U.S. patent protection runs out in ...

(RTTNews) - Merck (MRK) announced that Health Canada has granted approval for KEYTRUDA, Merck's anti-PD-1 therapy, as a treatment for adult patients with resectable Stage II, IIIA, or IIIB non ...

Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.

HYDERABAD, India (Reuters) - Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company ...

NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...